{"id":"https://openalex.org/W7213463191","doi":"https://doi.org/10.26434/chemrxiv.15008962/v1","title":"Constructing safe and highly potent antiviral neutralising nanodevices using a ferritin-based plug-and-play molecular assembly platform","display_name":"Constructing safe and highly potent antiviral neutralising nanodevices using a ferritin-based plug-and-play molecular assembly platform","publication_year":2026,"publication_date":"2026-09-16","ids":{"openalex":"https://openalex.org/W7213463191","doi":"https://doi.org/10.26434/chemrxiv.15008962/v1"},"language":"en","primary_location":{"id":"doi:10.26434/chemrxiv.15008962/v1","doi":"https://doi.org/10.26434/chemrxiv.15008962/v1","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.15008962/v1","pdf_url":"https://chemrxiv.org/doi/pdf/10.26434/chemrxiv.15008962/v1","source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://chemrxiv.org/doi/pdf/10.26434/chemrxiv.15008962/v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082720296","display_name":"Yujie Sheng","orcid":"https://orcid.org/0000-0002-4808-8545","observed_orcids":["https://orcid.org/0000-0002-4808-8545"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yujie Sheng","raw_affiliation_strings":["Institute of Pharmaceutical Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Science","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069816155","display_name":"Yasmin M. Surani","orcid":"https://orcid.org/0000-0002-6991-8739","observed_orcids":["https://orcid.org/0000-0002-6991-8739"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasmin M. Surani","raw_affiliation_strings":["Institute of Pharmaceutical Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Science","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151962562","display_name":"Alina Jansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alina Jansen","raw_affiliation_strings":["School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063860536","display_name":"Micka\u00ebl V. Cherrier","orcid":"https://orcid.org/0000-0003-0724-6663","observed_orcids":["https://orcid.org/0000-0003-0724-6663"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Micka\u00ebl V. Cherrier","raw_affiliation_strings":["School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103433398","display_name":"Lydie Martin","orcid":"https://orcid.org/0009-0005-8865-3499","observed_orcids":["https://orcid.org/0009-0005-8865-3499"]},"institutions":[{"id":"https://openalex.org/I4387153084","display_name":"UK Health Security Agency","ror":"https://ror.org/018h10037","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I4387153084"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lydie Martin","raw_affiliation_strings":["Countermeasures Development , Evaluation and Preparedness UK Health Security Agency Porton Down , Salisbury SP4 0JG , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Countermeasures Development , Evaluation and Preparedness UK Health Security Agency Porton Down , Salisbury SP4 0JG , UK","institution_ids":["https://openalex.org/I4387153084"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093900390","display_name":"El\u00e7in Su KARAVEL\u0130O\u011eLU","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elcin Su Karavelioglu","raw_affiliation_strings":["School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151946556","display_name":"Isobel A. Manterfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153084","display_name":"UK Health Security Agency","ror":"https://ror.org/018h10037","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I4387153084"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Isobel A. Manterfield","raw_affiliation_strings":["Countermeasures Development , Evaluation and Preparedness UK Health Security Agency Porton Down , Salisbury SP4 0JG , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Countermeasures Development , Evaluation and Preparedness UK Health Security Agency Porton Down , Salisbury SP4 0JG , UK","institution_ids":["https://openalex.org/I4387153084"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089893497","display_name":"Tam T. T. Bui","orcid":"https://orcid.org/0000-0002-8074-4928","observed_orcids":["https://orcid.org/0000-0002-8074-4928"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tam T. T. Bui","raw_affiliation_strings":["School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092969018","display_name":"Meritxell Wu\u2010Lu","orcid":"https://orcid.org/0009-0006-8130-6846","observed_orcids":["https://orcid.org/0009-0006-8130-6846"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Meritxell Wu-Lu","raw_affiliation_strings":["School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151955126","display_name":"Julia A. Tree","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Julia A. Tree","raw_affiliation_strings":["School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151939837","display_name":"Sally Yunsum Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I4387153084","display_name":"UK Health Security Agency","ror":"https://ror.org/018h10037","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I4387153084"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sally Yunsum Kim","raw_affiliation_strings":["Countermeasures Development , Evaluation and Preparedness UK Health Security Agency Porton Down , Salisbury SP4 0JG , UK","School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Countermeasures Development , Evaluation and Preparedness UK Health Security Agency Porton Down , Salisbury SP4 0JG , UK","institution_ids":["https://openalex.org/I4387153084"]},{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012078696","display_name":"Mar\u00eda Andrea Mroginski","orcid":"https://orcid.org/0000-0002-7497-5631","observed_orcids":["https://orcid.org/0000-0002-7497-5631"]},"institutions":[{"id":"https://openalex.org/I4387153084","display_name":"UK Health Security Agency","ror":"https://ror.org/018h10037","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I4387153084"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maria Andrea Mroginski","raw_affiliation_strings":["Countermeasures Development , Evaluation and Preparedness UK Health Security Agency Porton Down , Salisbury SP4 0JG , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Countermeasures Development , Evaluation and Preparedness UK Health Security Agency Porton Down , Salisbury SP4 0JG , UK","institution_ids":["https://openalex.org/I4387153084"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121058820","display_name":"J. Mark Sutton","orcid":"https://orcid.org/0000-0002-2288-0446","observed_orcids":["https://orcid.org/0000-0002-2288-0446"]},"institutions":[{"id":"https://openalex.org/I4387153084","display_name":"UK Health Security Agency","ror":"https://ror.org/018h10037","country_code":"GB","type":"government","lineage":["https://openalex.org/I1311074006","https://openalex.org/I4387153084"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Mark Sutton","raw_affiliation_strings":["Countermeasures Development , Evaluation and Preparedness UK Health Security Agency Porton Down , Salisbury SP4 0JG , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Countermeasures Development , Evaluation and Preparedness UK Health Security Agency Porton Down , Salisbury SP4 0JG , UK","institution_ids":["https://openalex.org/I4387153084"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030590912","display_name":"Yvain Nicolet","orcid":"https://orcid.org/0000-0002-4189-7067","observed_orcids":["https://orcid.org/0000-0002-4189-7067"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yvain Nicolet","raw_affiliation_strings":["School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016406473","display_name":"Kourosh Honarmand Ebrahimi","orcid":"https://orcid.org/0000-0001-6628-944X","observed_orcids":["https://orcid.org/0000-0001-6628-944X"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kourosh H. Ebrahimi","raw_affiliation_strings":["School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067385882","display_name":"Guy Schoehn","orcid":"https://orcid.org/0000-0002-1459-3201","observed_orcids":["https://orcid.org/0000-0002-1459-3201"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. Schoehn","raw_affiliation_strings":["School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016406473","display_name":"Kourosh Honarmand Ebrahimi","orcid":"https://orcid.org/0000-0001-6628-944X","observed_orcids":["https://orcid.org/0000-0001-6628-944X"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"KOUROSH Ebrahimi","raw_affiliation_strings":["School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK"],"raw_orcid":"https://orcid.org/0000-0001-6628-944X","affiliations":[{"raw_affiliation_string":"School of Cancer & Pharmaceutical Sciences King's College London Franklin-Wilkins Building , 150 Stamford Street London SE1 9NH , UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13326","display_name":"Biochemical and Structural Characterization","score":0.3822999894618988,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13326","display_name":"Biochemical and Structural Characterization","score":0.3822999894618988,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.26249998807907104,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.05139999836683273,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ferritin-nanocages","display_name":"ferritin nanocages","score":0.949999988079071},{"id":"https://openalex.org/keywords/antiviral-lectin","display_name":"antiviral lectin","score":0.8799999952316284},{"id":"https://openalex.org/keywords/intrinsically-disordered-peptides","display_name":"intrinsically disordered peptides","score":0.824999988079071},{"id":"https://openalex.org/keywords/influenza-a-virus","display_name":"influenza A virus","score":0.8809999823570251},{"id":"https://openalex.org/keywords/precision-cut-lung-slices","display_name":"precision-cut lung slices","score":0.7429999709129333},{"id":"https://openalex.org/keywords/pandemic-preparedness","display_name":"pandemic preparedness","score":0.9020000100135803}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5266000032424927},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.45080000162124634},{"id":"https://openalex.org/C2779574689","wikidata":"https://www.wikidata.org/wiki/Q2368907","display_name":"Arenavirus","level":5,"score":0.39629998803138733},{"id":"https://openalex.org/C206212055","wikidata":"https://www.wikidata.org/wiki/Q2553138","display_name":"Glycan","level":3,"score":0.37529999017715454},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3747999966144562},{"id":"https://openalex.org/C128355301","wikidata":"https://www.wikidata.org/wiki/Q6964001","display_name":"Nanocages","level":3,"score":0.3684000074863434},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.33719998598098755},{"id":"https://openalex.org/C2779756493","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral drug","level":3,"score":0.32429999113082886},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3240000009536743},{"id":"https://openalex.org/C202878990","wikidata":"https://www.wikidata.org/wiki/Q830465","display_name":"Capsid","level":3,"score":0.2759000062942505},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2750000059604645},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2745000123977661},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.26499998569488525},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.26350000500679016},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26109999418258667},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26100000739097595}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.26434/chemrxiv.15008962/v1","doi":"https://doi.org/10.26434/chemrxiv.15008962/v1","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.15008962/v1","pdf_url":"https://chemrxiv.org/doi/pdf/10.26434/chemrxiv.15008962/v1","source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.26434/chemrxiv.15008962/v1","doi":"https://doi.org/10.26434/chemrxiv.15008962/v1","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.15008962/v1","pdf_url":"https://chemrxiv.org/doi/pdf/10.26434/chemrxiv.15008962/v1","source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1088207598","display_name":null,"funder_award_id":"ANR-17-EURE-0003","funder_id":"https://openalex.org/F4320326245","funder_display_name":"R\u00e9gion Auvergne-Rh\u00f4ne-Alpes"},{"id":"https://openalex.org/G1488087311","display_name":"EXC 2008: Unifying Systems in Catalysis \"UniSysCat\"","funder_award_id":"390540038","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G1513157868","display_name":"CBH-EUR-GS","funder_award_id":"ANR-17-EURE-0003","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"},{"id":"https://openalex.org/G2228724986","display_name":null,"funder_award_id":"ANR-10-INBS-0005-02","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G256544642","display_name":null,"funder_award_id":"ANR-17-EURE-0003","funder_id":"https://openalex.org/F4320327185","funder_display_name":"French Infrastructure for Integrated Structural Biology"},{"id":"https://openalex.org/G2580110374","display_name":"Multifunctional nanomedicine prototypes acting as prophylactics and virus-assisted targeted drug delivery vehicle (NANOPROV)","funder_award_id":"MR/Y50337X/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G4399195447","display_name":null,"funder_award_id":"ANR-10-INBS-0005","funder_id":"https://openalex.org/F4320327185","funder_display_name":"French Infrastructure for Integrated Structural Biology"},{"id":"https://openalex.org/G678225801","display_name":null,"funder_award_id":"ANR-10-INBS-000502","funder_id":"https://openalex.org/F4320327185","funder_display_name":"French Infrastructure for Integrated Structural Biology"},{"id":"https://openalex.org/G6891474181","display_name":null,"funder_award_id":"ANR-17-EURE-0003","funder_id":"https://openalex.org/F4320315862","funder_display_name":"Infrastructures en Biologie Sant\u00e9 et Agronomie"},{"id":"https://openalex.org/G7259097847","display_name":null,"funder_award_id":"ANR-10-INBS","funder_id":"https://openalex.org/F4320327185","funder_display_name":"French Infrastructure for Integrated Structural Biology"},{"id":"https://openalex.org/G7350507296","display_name":null,"funder_award_id":"ANR-17-EURE-0003","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G7351664618","display_name":null,"funder_award_id":"ANR\u201017\u2010EURE\u20100003","funder_id":"https://openalex.org/F4320322892","funder_display_name":"Centre National de la Recherche Scientifique"},{"id":"https://openalex.org/G8136362559","display_name":null,"funder_award_id":"EXC 2008","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G869047677","display_name":"Infrastructure Fran\u00e7aise pour la Biologie Structurale Int\u00e9gr\u00e9e","funder_award_id":"ANR-10-INBS-0005","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"}],"funders":[{"id":"https://openalex.org/F4320315862","display_name":"Infrastructures en Biologie Sant\u00e9 et Agronomie","ror":"https://ror.org/054q97b08"},{"id":"https://openalex.org/F4320320285","display_name":"King's College London","ror":"https://ror.org/0220mzb33"},{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"},{"id":"https://openalex.org/F4320320883","display_name":"Agence Nationale de la Recherche","ror":"https://ror.org/00rbzpz17"},{"id":"https://openalex.org/F4320322892","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73"},{"id":"https://openalex.org/F4320326245","display_name":"R\u00e9gion Auvergne-Rh\u00f4ne-Alpes","ror":"https://ror.org/00kd6pz94"},{"id":"https://openalex.org/F4320327185","display_name":"French Infrastructure for Integrated Structural Biology","ror":"https://ror.org/045sst074"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7213463191.pdf","grobid_xml":"https://content.openalex.org/works/W7213463191.grobid-xml"},"referenced_works_count":3,"referenced_works":["https://openalex.org/W2938453597","https://openalex.org/W4376223996","https://openalex.org/W7134231015"],"related_works":["https://openalex.org/W2918359234","https://openalex.org/W4416517194","https://openalex.org/W4414146980","https://openalex.org/W4391321119","https://openalex.org/W4210336751","https://openalex.org/W4416427710","https://openalex.org/W4290546737","https://openalex.org/W7165839841","https://openalex.org/W3043427769","https://openalex.org/W4377011664"],"abstract_inverted_index":{"Viral":[0],"infections":[1],"are":[2],"a":[3,33,58,119,123,164],"global":[4],"threat.":[5],"Vaccines":[6],"and":[7,14,52,55,71,114,162,184],"antiviral":[8,40,72,78,181],"drugs":[9],"take":[10],"years":[11],"to":[12,21,84,112,178],"develop,":[13],"few":[15],"options":[16],"exist":[17],"for":[18,38,175],"rapid":[19],"response":[20],"viral":[22,49],"outbreaks.":[23],"To":[24],"address":[25],"this":[26],"gap":[27],"in":[28,147],"pandemic":[29],"preparedness,":[30],"we":[31,74],"advance":[32],"\u201cplug-and-play\u201d":[34],"nanocage":[35,168,189],"assembly":[36,85],"platform":[37],"constructing":[39],"nanodevices":[41],"(AVNs),":[42],"defined":[43],"as":[44],"nanocages":[45],"that":[46,76,128],"physically":[47],"bind":[48],"surface":[50],"glycoproteins":[51],"block":[53],"entry":[54],"infection.":[56],"Using":[57],"multidisciplinary":[59],"approach":[60],"combining":[61],"molecular":[62],"dynamics":[63],"(MD)":[64],"simulations,":[65],"biochemical":[66],"assays,":[67,73],"Cryo-EM":[68],"structural":[69],"analysis,":[70],"show":[75,127],"different":[77],"lectins":[79],"can":[80],"be":[81],"genetically":[82],"fused":[83],"precursors":[86,106],"designed":[87],"by":[88],"linking":[89],"two":[90],"ferritin":[91,124],"subunits":[92],"with":[93,118,143],"an":[94,100],"intrinsically":[95],"disordered":[96],"peptide":[97],"(IDP)":[98],"containing":[99],"enterokinase":[101],"cleavage":[102],"site.":[103],"The":[104],"resulting":[105],"significantly":[107],"improved":[108],"(>2-fold)":[109],"lectin":[110],"binding":[111],"glycans":[113],"assembled":[115],"into":[116,158,188],"AVNs":[117,129,177],"core":[120],"structure":[121],"resembling":[122],"nanocage.":[125],"We":[126],"have":[130],"potent":[131],"activity":[132],"against":[133],"influenza":[134],"A":[135],"virus":[136],"(IAV)":[137],"(IC50":[138],"values":[139],"<":[140],"1":[141],"nM),":[142],"no":[144],"toxicity":[145],"observed":[146],"ex":[148],"vivo":[149],"precision-cut":[150],"lung":[151],"slices":[152],"(PCLS).":[153],"Our":[154],"data":[155],"revealed":[156],"insight":[157],"precursor":[159],"design":[160],"rules":[161],"suggest":[163],"stepwise":[165],"mechanism":[166],"of":[167],"assembly.":[169,190],"These":[170],"findings":[171],"pave":[172],"the":[173],"way":[174],"using":[176],"develop":[179],"novel":[180],"preventive":[182],"strategies":[183],"provide":[185],"fundamental":[186],"insights":[187]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-17T00:00:00"}